Stocks Comparison
Anheuser-Busch InBev vs Molson Coors Beverage: revenue, profit, margins and growth compared
Anheuser-Busch InBev brought in $59.3B of revenue in fiscal 2025, Molson Coors Beverage $13B in fiscal 2025. Revenue changed by -0.7% at Anheuser-Busch InBev and -5.1% at Molson Coors Beverage on the year before, so Anheuser-Busch InBev grew faster. Anheuser-Busch InBev kept 11.5% of its revenue as net profit, Molson Coors Beverage -16.4%. Free cash flow was $11.2B at Anheuser-Busch InBev and $1.1B at Molson Coors Beverage.
Side by side, latest fiscal year
| BUD | TAP | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $59.3B | $13B |
| Revenue growth | -0.7% | -5.1% |
| Net income | $6.8B | -$2.1B |
| Net margin | 11.5% | -16.4% |
| Free cash flow | $11.2B | $1.1B |
| Free cash flow margin | 18.9% | 8.2% |
| Earnings per share (diluted) | $3.39 | -$10.75 |
| Cash | $11.6B | $896.5M |
| Debt | $73B | $6.3B |
| Price to earnings | n/a | n/a |
| Market value | $153.8B | $6.7B |
| Dividend yield | n/a | 5.23% |
| Rank by revenue in sector | #8 of 125 · Consumer staples | #19 of 125 · Consumer staples |
Over the years
Questions about Anheuser-Busch InBev and Molson Coors Beverage
Which is bigger by revenue, Anheuser-Busch InBev or Molson Coors Beverage?
Anheuser-Busch InBev is bigger by revenue: $59.3B in fiscal 2025, against $13B for Molson Coors Beverage in fiscal 2025.
Which keeps more of its revenue as profit, Anheuser-Busch InBev or Molson Coors Beverage?
Anheuser-Busch InBev had a net margin of 11.5% in fiscal 2025; Molson Coors Beverage had -16.4% in fiscal 2025.
Which grew revenue faster, Anheuser-Busch InBev or Molson Coors Beverage?
In their latest fiscal years revenue changed by -0.7% at Anheuser-Busch InBev and -5.1% at Molson Coors Beverage.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.